Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286870 · ClinicalTrials.gov registry record · Phase 4
Becker Continued Access Study
A Phase 4 study, sponsored by Mentor Worldwide.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT01286870: Clinical Trial Phase 4 study, sponsored by Mentor Worldwide.
NCT01286870 is a Phase 4 study that was terminated before completion, run by Mentor Worldwide. The registered enrollment target is 11 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286870, a Phase 4 study, was terminated before completion, sponsored by Mentor Worldwide.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
While Core Becker patient follow-up is being completed this Continued Access Study is designed to enroll patients at a limited rate per month to allow for continued physician and patient experience with the device. Up to 12 patients per month at sites across the United States will be enrolled in this research study. These patients will be implanted with the Becker 25 or Becker 50 Expander/Breast implant and monitored for 10 years for safety.
Interventions
- DEVICE Mentor Becker 25 Expander/Breast Implant
- DEVICE Mentor Becker 50 Expander/Breast Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2009-06-01 |
| Est. Completion | 2014-03-04 |
| Phase | Phase 4 |
Why NCT01286870 stopped before completion
NCT01286870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Mentor Becker 25 Expander/Breast Implant is the first listed.
NCT01286870 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01286870 about?
NCT01286870 is a clinical study titled "Becker Continued Access Study". While Core Becker patient follow-up is being completed this Continued Access Study is designed to enroll patients at a limited rate per month to allow for continued physician and patient experience with the device. Up to 12 patients per month at sites across the United States will be enrolled in th...
What is the current status of trial NCT01286870?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2009-06-01. Estimated completion is 2014-03-04.
What interventions are being tested in trial NCT01286870?
The interventions under investigation include: Mentor Becker 25 Expander/Breast Implant (DEVICE), Mentor Becker 50 Expander/Breast Implant (DEVICE).
Who is sponsoring clinical trial NCT01286870?
This trial is sponsored by Mentor Worldwide, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286870's enrollment target sits among peer trials
11 1931st of 2000 higher than 61 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI